Novocure (NVCR), a global oncology company that employs TTFields to treat cancer, has a clinical trial catalyst to watch in the coming months.
The Tumor Treating Fields (TTFields) are electric fields that disrupt cancer cell division. The company is focused on the manufacture and commercialization of Tumor Treating Fields devices, designed to extend survival in some of the most aggressive forms of cancer. Its commercially available TTFields devices include Optune Gio and Optune Lua.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com